中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
26期
33-33,36
,共2页
杨晶晶%刘帅斌%胡丽娜
楊晶晶%劉帥斌%鬍麗娜
양정정%류수빈%호려나
阿司匹林%肝素%复发性流产%抗磷脂抗体
阿司匹林%肝素%複髮性流產%抗燐脂抗體
아사필림%간소%복발성유산%항린지항체
Aspirin%Heparin%Recurrent miscarriage%Anti phospholipid antibody
目的：探讨普通肝素与低分子肝素治疗抗磷脂抗体阳性复发性流产的疗效。方法：采用Cochrane协作网系统评价方法，对有关普通肝素与低分子肝素治疗抗磷脂抗体阳性复发性流产研究进行质量评价。结果：低分子肝素组的胎儿流产风险是普通肝素组的0.59倍；低分子肝素组治疗复发性流产妇女最终导致其并发症的发生风险是普通肝素组的1.34倍，但差异均无统计学意义(P＞0.05)。结论：普通肝素与低分子肝素治疗抗磷脂抗体阳性复发性流产的临床疗效无差异。
目的：探討普通肝素與低分子肝素治療抗燐脂抗體暘性複髮性流產的療效。方法：採用Cochrane協作網繫統評價方法，對有關普通肝素與低分子肝素治療抗燐脂抗體暘性複髮性流產研究進行質量評價。結果：低分子肝素組的胎兒流產風險是普通肝素組的0.59倍；低分子肝素組治療複髮性流產婦女最終導緻其併髮癥的髮生風險是普通肝素組的1.34倍，但差異均無統計學意義(P＞0.05)。結論：普通肝素與低分子肝素治療抗燐脂抗體暘性複髮性流產的臨床療效無差異。
목적：탐토보통간소여저분자간소치료항린지항체양성복발성유산적료효。방법：채용Cochrane협작망계통평개방법，대유관보통간소여저분자간소치료항린지항체양성복발성유산연구진행질량평개。결과：저분자간소조적태인유산풍험시보통간소조적0.59배；저분자간소조치료복발성유산부녀최종도치기병발증적발생풍험시보통간소조적1.34배，단차이균무통계학의의(P＞0.05)。결론：보통간소여저분자간소치료항린지항체양성복발성유산적림상료효무차이。
Objective:To investigate the efficacy of common heparin and low molecular heparin in the treatment of anti phospholipid antibody positive recurrent spontaneous abortion.Methods:We adopted the cochrane cooperative network system evaluation method,to do the quality evaluation of the common heparin and low molecular heparin in the treatment of anti phospholipid antibody positive recurrent spontaneous abortion.Results:Low molecular heparin group fetal risk of miscarriage is unfractionated heparin group 0.59 times;low molecular weight heparin group treatment of women with recurrent spontaneous abortion ultimately lead to the complication risk is unfractionated heparin group of 1.34 times,but the difference was not statistically significant (P>0.05).Conclusion:There is no difference between the clinical efficacy of ordinary heparin and low molecular heparin in the treatment of anti phospholipid antibody positive recurrent miscarriage.
